Intravenous infusion of magnesium sulfate is not associated with cardiovascular, liver, kidney, and metabolic toxicity in adults
Journal Title: Journal of Clinical and Translational Research - Year 2018, Vol 4, Issue 1
Abstract
Background: Magnesium (Mg) deficiency contributes to the pathophysiology of numerous diseases. The therapeutic use of Mg has steadily increased over time. The increased in-hospital use of intravenous (IV) magnesium sulfate (MgSO4) warrants more extensive investigation regarding the safety of the therapy. The aim of this study was to determine the safety of IV MgSO4 infusion on cardiovascular, liver, kidney, and metabolic markers in adults. Methods: Twelve volunteers were randomized to one of two cross-over conditions: (a) IV infusion of MgSO4 in 5% dextrose followed by IV infusion of 5% dextrose 1 week later or (b) IV infusion of 5% dextrose followed by IV infusion of MgSO4 in 5% dextrose 1 week later. An electrocardiogram was recorded continuously during the infusions. Blood was drawn pre- and post-infusion for blood count (high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides). Results: Serum Mg increased from pre- to post-infusion in the MgSO4 + 5% dextrose group (p < 0.0001). The QRS interval length increased from pre- to post-infusion in the MgSO4 + 5% dextrose group (p <0.04). Additionally, serum glucose concentration increased in the MgSO4 + 5% dextrose group (p =0.04). These significant findings were modeled with gender and age as covariates. No other significant differences were found. Conclusions: The administration of IV infusion of MgSO4 (4 g/100 mL) in 5% dextrose over a 4-hour treatment period poses no significant deleterious effects on cardiovascular, liver, kidney, or metabolic function. Relevance for patients: IV infusion of MgSO4 may be used for certain treatment indications without significant concern for systemic or organ toxicity.
Authors and Affiliations
Elisa Karhu, Steven E. Atlas1, Jinrun Gao, Syed A. Mehdi, Dominique Musselman, Sharon Goldberg,Judi M. Woolger, Raul Corredor, Muhammad H. Abbas, Leopoldo Arosemena, Simone Caccamo, Ashar Farooqi, Janet Konefal, Laura Lantigua, Vanessa Padilla, Ammar Rasul, Eduard Tiozzo, Oscar L. Higuera, Andrea Fiallo, John E. Lewis
Keywords
Related Articles
- EP ID EP678768
- DOI -
- Views 186
- Downloads 0
Lack of direct cytotoxicity of extracellular ATP against hepatocytes: role in the mechanism of acetaminophen hepatotoxicity
Background: Acetaminophen (APAP) hepatotoxicity is a major cause of acute liver failure in many countries. Mechanistic studies in mice and humans have implicated formation of a reactive metabolite, mitochondrial dysfunct...
Anti-cancer effects of aloe-emodin: a systematic review
Background: Anthraquinones are a possible treatment option for oncological patients due to their anti-cancer properties. Cancer patients often exhaust a plethora of resources that ultimately fail to provide fully curativ...
High-intensity, but not moderate-intensity, exercise increases post-exercise rate of fat oxidation in type 2 diabetics
Background: Aerobic exercise is recommended for glycemic and weight control in type 2 diabetes (T2D), but exercise intensity that increase post-exercise fat oxidation has not been established yet. It is expected that hig...
Immune mechanisms of idiosyncratic drug-induced liver injury
Idiosyncratic drug reactions (IDRs) continue to be an important issue. Specifically, idiosyncratic drug-induced liver injury (IDILI) is the most likely IDR to lead to drug withdrawal, and it accounts for a significant po...
TEMPOL has limited protective effects on renal oxygenation and hemodynamics but reduces kidney damage and inflammation in a rat model of renal ischemia/reperfusion by aortic clamping
Background: Renal ischemia-reperfusion (I/R) is a common clinical complication in critically ill patients that is associated with considerable morbidity and mortality. Renal I/R is a major cause of acute kidney injury (A...